BCM
CALA

Bridgeway Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Bridgeway Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,175
Closed -$74K – 1409
2022
Q1 		$74K Hold
9,175
– – ﹤0.01% 1278
2021
Q4 		$122K Sell
9,175
-7,500
-45% -$188K ﹤0.01% 1205
2021
Q3 		$727K Buy
16,675
+1,675
+11% +$72.3K 0.01% 924
2021
Q2 		$627K Buy
+15,000
New +$659K 0.01% 1005
2020
Q1 		– Sell
-10,100
Closed -$1.15M – 1384
2019
Q4 		$1.15M Hold
10,100
– – 0.02% 708
2019
Q3 		$624K Buy
10,100
+2,500
+33% +$200K 0.01% 863
2019
Q2 		$593K Buy
7,600
+1,250
+20% +$142K 0.01% 923
2019
Q1 		$856K Buy
6,350
+500
+9% +$52.5K 0.01% 816
2018
Q4 		$469K Buy
5,850
+2,500
+75% +$247K 0.01% 1018
2018
Q3 		$352K Sell
3,350
-3,720
-53% -$354K ﹤0.01% 1219
2018
Q2 		$707K Hold
7,070
– – 0.01% 1014
2018
Q1 		$891K Buy
7,070
+4,690
+197% +$731K 0.01% 892
2017
Q4 		$397K Sell
2,380
-1,023
-30% -$262K ﹤0.01% 1157
2017
Q3 		$1.07M Sell
3,403
-2,977
-47% -$939K 0.01% 826
2017
Q2 		$1.9M Hold
6,380
– – 0.02% 602
2017
Q1 		$1.47M Sell
6,380
-1,525
-19% -$263K 0.02% 672
2016
Q4 		$514K Buy
7,905
+12
+0.2% +$750 0.01% 1081
2016
Q3 		$513K Hold
7,893
– – 0.01% 1094
2016
Q2 		$586K Buy
7,893
+4,000
+103% +$401K 0.01% 975
2016
Q1 		$442K Hold
3,893
– – 0.01% 1105
2015
Q4 		$596K Buy
3,893
+2,368
+155% +$355K 0.01% 986
2015
Q3 		$166K Buy
+1,525
New +$198K ﹤0.01% 1336

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgeway Capital Management's CALA Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 9,175 shares — an estimated $74K sold.

Bridgeway Capital Management first reported a position in CALA in Q3 2015 and held it in 22 quarters. The position peaked at $1.9M in Q2 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Bridgeway Capital Management reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 9,175 Calithera Biosciences, Inc shares in Q2 2022, an estimated $74K.
  • Bridgeway Capital Management first reported a position in Calithera Biosciences, Inc in Q3 2015 and held it in 22 quarters.
  • Bridgeway Capital Management's Calithera Biosciences, Inc position peaked at $1.9M in Q2 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.